Influence of prostaglandins on adrenergic transmission to vascular smooth muscle.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004558:Electric Stimulation; D005260:Female; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D011941:Receptors, Adrenergic / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D012501:Saphenous Vein / Q000187:drug effects; D012867:Skin / Q000294:innervation; D009435:Synaptic Transmission / Q000187:drug effects*; D014439:Tyramine / Q000037:antagonists & inhibitors; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D011453:Prostaglandins; D011941:Receptors, Adrenergic; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D000804:Angiotensin II; D009638:Norepinephrine; D014439:Tyramine